Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs78484963 | chr17:1410697 | T/C | 0.000277 | 173 | 25.53 | 23.08 | 14.43 | KM Plot |
PCPG | rs78495928 | chr12:56635080 | G/C | 1.1E-7 | 177 | 25.08 | 29.13 | 0.8 | KM Plot |
PCPG | rs78530336 | chr16:89899055 | T/C | 0.000176 | 174 | 25.87 | 22.63 | 36.37 | KM Plot |
PCPG | rs78606324 | chr2:228479109 | CA/C | 5.29E-11 | 176 | 24.7 | 36.7 | 10.3 | KM Plot |
PCPG | rs78645162 | chr7:36172761 | G/A | 0.000411 | 178 | 25.67 | 24.6 | 14.37 | KM Plot |
PCPG | rs78749928 | chr18:51842886 | A/C | 4.78E-11 | 176 | 24.93 | 34.73 | 10.3 | KM Plot |
PCPG | rs78772509 | chr22:21283601 | T/C | 7.74E-5 | 177 | 12.93 | 31.47 | 25.2 | KM Plot |
PCPG | rs78789990 | chr11:68138001 | G/A | 0.000275 | 170 | 25 | 26.85 | 19.87 | KM Plot |
PCPG | rs78807390 | chr2:241525314 | C/A | 7.15E-12 | 178 | 25.77 | 24.62 | 6.73 | KM Plot |
PCPG | rs78810275 | chr2:176181090 | C/T | 0.000115 | 178 | 25.28 | 28.95 | 6.62 | KM Plot |
PCPG | rs78818156 | chr10:50516965 | A/G | 3.98E-6 | 177 | 24.5 | 34.47 | 25.17 | KM Plot |
PCPG | rs78850050 | chr16:89823009 | CAAAG/C | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs78907385 | chr7:158674600 | T/C | 0 | 177 | 25.53 | 20.37 | 3.17 | KM Plot |
PCPG | rs78923197 | chr3:39772634 | C/G | 9.42E-8 | 175 | 25.77 | 19.88 | 19.87 | KM Plot |
PCPG | rs79006456 | chr16:71638639 | T/G | 1.04E-5 | 175 | 23.43 | 30.93 | 14.5 | KM Plot |